https://doi.org/10.31288/oftalmolzh201466065

Retrospective study of anterior eye segment purulent-inflammatory diseases' etiology structure

Nazarchuk G. G., Saldan Yu. I., Nazarchuk O. A.

Vinnitsa National M. I. Pyrogov Memorial Medical University  

Eye of eye diseases inflammatory diseases occupy the first position in the structure (34,5- 40,2 %).

Aim of the research was to investigate anterior segment eye and eyelids purulent-inflammatory diseases' etiology structure; microorganisms' sensitivity to antibiotics. Material and Methods. The bacteriologic examinations' results of 43 patients with anterior segment eye and eyelids purulent-inflammatory diseases were retrospectively analyzed. All the patients were observed in Vinnitsa or Zhytomyr Region Clinical Hospitals during 2013 year.

Results. Etiology structure of purulent-inflammatory diseases of anterior eye segment and eyelids included gram-positive (89.7 %), in particular: S. epidermidis (55.2 %), S. aureus (20.8 %), S. viridans (5.2 %), E. faecalis (3.4 %), S. heamo-liticus (1.7 %), S. pneumoniae (1.7 %), C. hofmannii (1.7 %) and gram-negative bacteria Acinetobacter spp. (5.2 %), E.coli (3.4 %), E. gergoviae (1.7 %). The Staphylococcus spp. sensitivity to penicillins (50.0-78.1 %), cephalosporins (50.0—71.9 %), macrolides (50.0—58.3 %) was low. It was variable to ciprofloxacin (66.7-78.1 %); ofloxacin (75.0—87.5 %), moxyfloxacin (75.0—84.4 %), gentamycin (66.7—90.6 %), tobramycin (66.7—93.8 %). Gram-negative bacteria had low sensitivity to antibiotics.

Conclusions. Gram-positive microorganisms are cause inflammatory diseases of anterior segment eye and eyelids in most cases (89.7 %) and have variable sensitivity to antibiotics. Gram-negative bacteria has low sensitivity to the majority of antibiotics.

Key words: inflammatory diseases of the eye, antibiotics

References

1.Zapuskalov IV, Krivosheina OI. Modern trends in traumatic injuries reconstructive surgery of the anterior segment of the eye (literature review). Oftalmokhirurgiia. 2013;2:59. Russian.

2.Maichuk YuF. Current trends in the epidemiology and treatment ofeye infections./ Okulist. 2005;6(74):8-9. Russian.

3.Bhoomibunchoo C, Ratanapakorn T, Sinawat S. Infectious endophthalmitis: review of 420 cases. Clinical Ophthalmology. 2013;7:247- 52.
Crossref

4.Chen X, Adelman RA. Microbial spectrum and resistance patterns in endophthalmitis: a 21-year (1988- 2008) review in northeast United States. J Ocul Pharmacol Ther. 2012;28(4):329- 34.
Crossref

5.Durand ML. Endophthalmitis. Clinical Microbiology and Infection. 2013;19(3):227- 34.
Crossref

6.Schimel AM, Miller D, Flynn HW Jr., Endophthalmitis iso-lates and antibiotic susceptibilities: a 10-year review of culture-proven cases. Am J Ophthalmol. 2013;156(1):50- 2.
Crossref